Recent evidence from three Stmn2 loss of function mouse models strongly support that the loss of STMN2 contributes to ALS (Guerra San Juan et al., 2022; Krus et al., 2022; Lopez-Erauskin et al., 2022). Here, STMN2 is linked to amyotrophic lateral sclerosis.